Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD.

Chieh-Li YenPei-Chun FanMing-Shyan LinCheng-Chia LeeKun-Hua TuChao-Yu ChenChing-Chung HsiaoHsiang-Hao HsuYa-Chung TianChih-Hsiang Chang

Published in: The Journal of clinical endocrinology and metabolism (2021)

For patients with advanced CKD, continuing fenofibrate may provide a protective effect on CV outcomes equal to that of statins, and it may further delay the need for permanent dialysis. The combination of fenofibrate and high-intensity statins may have additional benefits.

Keyphrases

chronic kidney disease
high intensity
end stage renal disease
cardiovascular disease
resistance training
peritoneal dialysis
type diabetes
metabolic syndrome
glycemic control